Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Methylation of dual-specificity phosphatase 4 controls cell differentiation.

Cell reports | 2021

Mitogen-activated protein kinases (MAPKs) are inactivated by dual-specificity phosphatases (DUSPs), the activities of which are tightly regulated during cell differentiation. Using knockdown screening and single-cell transcriptional analysis, we demonstrate that DUSP4 is the phosphatase that specifically inactivates p38 kinase to promote megakaryocyte (Mk) differentiation. Mechanistically, PRMT1-mediated methylation of DUSP4 triggers its ubiquitinylation by an E3 ligase HUWE1. Interestingly, the mechanistic axis of the DUSP4 degradation and p38 activation is also associated with a transcriptional signature of immune activation in Mk cells. In the context of thrombocytopenia observed in myelodysplastic syndrome (MDS), we demonstrate that high levels of p38 MAPK and PRMT1 are associated with low platelet counts and adverse prognosis, while pharmacological inhibition of p38 MAPK or PRMT1 stimulates megakaryopoiesis. These findings provide mechanistic insights into the role of the PRMT1-DUSP4-p38 axis on Mk differentiation and present a strategy for treatment of thrombocytopenia associated with MDS.

Pubmed ID: 34320342 RIS Download

Antibodies used in this publication

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK110574
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM126154
  • Agency: NCI NIH HHS, United States
    Id: T32 CA062948
  • Agency: NCI NIH HHS, United States
    Id: P30 CA008748
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM122749
  • Agency: BLRD VA, United States
    Id: IK6 BX003617
  • Agency: NIGMS NIH HHS, United States
    Id: R35 GM131858
  • Agency: NCI NIH HHS, United States
    Id: R21 CA202390
  • Agency: BLRD VA, United States
    Id: I01 BX004426

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PhosphoSitePlus: Protein Modification Site (tool)

RRID:SCR_001837

A freely accessible on-line systems biology resource devoted to all aspects of protein modification, as well as other post-translational modifications. It provides valuable and unique tools for both cell biologists and mass spectroscopists. PhosphoSite is a human- and mouse-centric database. It includes features such as: viewing the locations of modified residues on molecular models; browsing and searching MS2 records by disease, tissue, and cell line; submitting lists of peptides to identify previously reported genes; searching by sub-cellular localization, treatment, tissues, cell types, cell lines and diseases, and protein types and protein domains; searching for experimentally-verified kinase substrates and viewing preferred substrate motifs; and viewing MS2 spectra for peptides and sites not previously published.

View all literature mentions

ClinicalTrials.gov (tool)

RRID:SCR_002309

Registry and results database of federally and privately supported clinical trials conducted in United States and around world. Provides information about purpose of trial, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.Offers information for locating federally and privately supported clinical trials for wide range of diseases and conditions. Research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings. ClinicalTrials.gov contains trials sponsored by National Institutes of Health, other federal agencies, and private industry. Studies listed in database are conducted in all 50 States and in 178 countries.

View all literature mentions

STAR (tool)

RRID:SCR_004463

Software performing alignment of high-throughput RNA-seq data. Aligns RNA-seq reads to reference genome using uncompressed suffix arrays.

View all literature mentions

PRISM (tool)

RRID:SCR_005375

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.

View all literature mentions

Magic (tool)

RRID:SCR_006406

Web based interface for exploring and analyzing a comprehensive maize-specific cross-platform expression compendium. This compendium was constructed by collecting, homogenizing and formally annotating publicly available microarrays from Gene Expression Omnibus (GEO), and ArrayExpress.

View all literature mentions

Thermo Xcalibur (tool)

RRID:SCR_014593

A software which acquires and processes data sets, primarily through the Xcalibur system.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

p44/42 MAPK (Erk1/2) Antibody (antibody)

RRID:AB_330744

This polyclonal targets p44/42 MAPK (Erk1/2)

View all literature mentions

GAPDH Loading Control Monoclonal Antibody (GA1R) (antibody)

RRID:AB_10977387

This monoclonal targets GAPDH Loading Control

View all literature mentions

Anti-HA Tag (antibody)

RRID:AB_11213751

This monoclonal targets HA Tag

View all literature mentions

DUSP4/MKP2 (D9A5) (antibody)

RRID:AB_2750867

This monoclonal targets Dual specificity protein phosphatase 4

View all literature mentions

MKP-2 (S-18) (antibody)

RRID:AB_2095314

This polyclonal targets MKP-2 (S-18)

View all literature mentions

donkey anti-mouse IgG-HRP (antibody)

RRID:AB_641170

This polyclonal targets donkey anti-mouse IgG-HRP

View all literature mentions

goat anti-rabbit IgG-HRP (antibody)

RRID:AB_631746

This polyclonal targets goat anti-rabbit IgG-HRP

View all literature mentions

p-p38 (Thr 180/Tyr 182)-R (antibody)

RRID:AB_2139810

This polyclonal targets Mapk14

View all literature mentions

p-ERK (Tyr 204) (antibody)

RRID:AB_2297323

This polyclonal targets MAPK3

View all literature mentions

p38alpha (9F12) (antibody)

RRID:AB_1127392

This monoclonal targets Human MAPK14

View all literature mentions

Alpha Tubulin antibody (antibody)

RRID:AB_11042766

This monoclonal targets Alpha Tubulin

View all literature mentions

CD41 (antibody)

RRID:AB_10896980

This monoclonal targets CD41

View all literature mentions

Phospho-S6 Ribosomal Protein (Ser235/236) (D57.2.2E) XP Rabbit mAb (PE Conjugate) (antibody)

RRID:AB_10694989

This monoclonal targets Phospho-S6 Ribosomal Protein (Ser235/236) (D57.2.2E) XP Rabbit mAb (PE Conjugate)

View all literature mentions

CD41a (antibody)

RRID:AB_395859

This monoclonal targets CD41a

View all literature mentions

Anti-Ubiquitin (antibody)

RRID:AB_11205591

This polyclonal targets Ubiquitin

View all literature mentions

MEG-01 (cell line)

RRID:CVCL_0425

Cell line MEG-01 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NB4 (cell line)

RRID:CVCL_0005

Cell line NB4 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

K-562 (cell line)

RRID:CVCL_0004

Cell line K-562 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

CMK (cell line)

RRID:CVCL_0216

Cell line CMK is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions